Closing the gaps in recruitment and retention in cancer trials: sufficient evidence but poor implementation.
作者信息
Pellizzari Giulia
机构信息
CRUK & UCL Cancer Trials Centre, Cancer Institute, University College London, London, UK.
出版信息
BMJ Oncol. 2023 Nov 20;2(1):e000195. doi: 10.1136/bmjonc-2023-000195. eCollection 2023.
Abstract
摘要
相似文献
1
Closing the gaps in recruitment and retention in cancer trials: sufficient evidence but poor implementation.缩小癌症试验中招募和留住参与者方面的差距：证据充分但实施不力。
BMJ Oncol. 2023 Nov 20;2(1):e000195. doi: 10.1136/bmjonc-2023-000195. eCollection 2023.
2
Recruitment and retention challenges and strategies in randomized controlled trials of psychosocial interventions for children with cancer and their parents: a collective case study.心理社会干预在儿童癌症及其父母的随机对照试验中的招募和保留挑战与策略：一项集合案例研究。
Eur J Pediatr. 2023 Oct;182(10):4683-4706. doi: 10.1007/s00431-023-05139-1. Epub 2023 Aug 10.
3
A multilevel framework for recruitment and retention in implementation trials: An illustrative example.实施试验中招募与留用的多层次框架：一个示例
Clin Trials. 2025 Jun;22(3):325-341. doi: 10.1177/17407745241307948. Epub 2025 Jan 10.
4
Undertaking Studies Within A Trial to evaluate recruitment and retention strategies for randomised controlled trials: lessons learnt from the PROMETHEUS research programme.在一项评估随机对照试验招募和保留策略的试验中进行研究：从 PROMETHEUS 研究计划中吸取的经验教训。
Health Technol Assess. 2024 Jan;28(2):1-114. doi: 10.3310/HTQW3107.
5
Closing the gap in implementation of HIV clinical guidelines in a low resource setting using electronic medical records.利用电子病历缩小资源匮乏环境下 HIV 临床指南实施中的差距。
BMC Health Serv Res. 2020 Aug 26;20(1):804. doi: 10.1186/s12913-020-05613-8.
6
Access and Representation: A Narrative Review of the Disparities in Access to Clinical Trials and Precision Oncology in Black men with Prostate Cancer.可及性与代表性：一项关于黑人男性前列腺癌患者参与临床试验和精准肿瘤学机会不均等的叙述性综述。
Urology. 2022 May;163:90-98. doi: 10.1016/j.urology.2021.09.004. Epub 2021 Sep 25.
7
Behavioural approaches to recruitment and retention in clinical trials: a systematic mapping review.行为学方法在临床试验招募和保留中的应用：系统综述。
BMJ Open. 2022 Mar 9;12(3):e054854. doi: 10.1136/bmjopen-2021-054854.
8
Recruitment and Retention Strategies for Historically Marginalized Populations in Colorectal Cancer Trials: A Cross-Sectional Analysis Using Systematic Review Methods.招募和保留结直肠癌试验中历史上被边缘化人群的策略：使用系统评价方法的横断面分析。
J Gastrointest Cancer. 2024 Nov 26;56(1):24. doi: 10.1007/s12029-024-01146-z.
9
Retention rates and reasons for non-retention in exercise oncology trials in the post-treatment phase-a systematic review.治疗后阶段运动肿瘤学试验中的保留率及未保留原因——一项系统综述
J Cancer Surviv. 2024 Apr 3. doi: 10.1007/s11764-024-01569-4.
10
Global Oncology Nursing Recruitment and Retention: A SWOT Analysis.全球肿瘤护理人员的招聘与留用：SWOT 分析
Semin Oncol Nurs. 2023 Feb;39(1):151361. doi: 10.1016/j.soncn.2022.151361. Epub 2023 Jan 7.
本文引用的文献
1
It Is Time to Close the Gap in Cancer Care.是时候缩小癌症治疗的差距了。
JCO Glob Oncol. 2023 Jan;9:e2200429. doi: 10.1200/GO.22.00429.
2
Racial and Ethnic Disparities in Cancer Care During the COVID-19 Pandemic.癌症护理在 COVID-19 大流行期间的种族和民族差异。
JAMA Netw Open. 2022 Jul 1;5(7):e2222009. doi: 10.1001/jamanetworkopen.2022.22009.
3
Barriers to patient enrolment in phase III cancer clinical trials: interviews with clinicians and pharmaceutical industry representatives.癌症三期临床试验中患者入组的障碍：对临床医生和制药行业代表的访谈。
BMJ Open. 2022 Feb 17;12(2):e055165. doi: 10.1136/bmjopen-2021-055165.
4
Patient and public involvement for ethnic minority research: an urgent need for improvement.少数民族研究中的患者和公众参与：亟待改进。
J R Soc Med. 2021 Jul;114(7):347-350. doi: 10.1177/0141076821994274. Epub 2021 Feb 24.
5
Sociodemographic diversity in cancer clinical trials: New findings on the effect of race and ethnicity.癌症临床试验中的社会人口学多样性：关于种族和族裔影响的新发现。
Contemp Clin Trials Commun. 2021 Jan 20;21:100718. doi: 10.1016/j.conctc.2021.100718. eCollection 2021 Mar.
6
Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process.制定改善服务不足群体试验交付的路线图：来自英国多方利益相关者进程的结果。
Trials. 2020 Aug 1;21(1):694. doi: 10.1186/s13063-020-04613-7.
7
Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis.患者和公众参与对临床试验入组和保留的影响：系统评价和荟萃分析。
BMJ. 2018 Nov 28;363:k4738. doi: 10.1136/bmj.k4738.
8
Immuno-oncology Clinical Trial Design: Limitations, Challenges, and Opportunities.免疫肿瘤学临床试验设计：局限性、挑战和机遇。
Clin Cancer Res. 2017 Sep 1;23(17):4992-5002. doi: 10.1158/1078-0432.CCR-16-3066.
9
Participation in cancer clinical trials: why are patients not participating?参与癌症临床试验：患者为何不参与？
Med Decis Making. 2014 Jan;34(1):116-26. doi: 10.1177/0272989X13497264. Epub 2013 Jul 29.
Zotero 插件